CIG
Cairn Investment Group Portfolio holdings
AUM
$191M
This Quarter Return
-16.81%
1 Year Return
+13.86%
3 Year Return
+60.88%
5 Year Return
+118.9%
10 Year Return
–
AUM
$67.2M
AUM Growth
+$67.2M
(-33%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-21.04%
Top 10 Holdings %
Top 10 Hldgs %
35.62%
Holding
89
New
1
Increased
16
Reduced
41
Closed
23
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$1.93M |
| 2 |
3M
MMM
|
$1.13M |
| 3 |
Qualcomm
QCOM
|
$1.13M |
| 4 |
iShares Short Treasury Bond ETF
SHV
|
$923K |
| 5 |
Gilead Sciences
GILD
|
$778K |
Top Sells
| 1 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
$2.42M |
| 2 |
Weyerhaeuser
WY
|
$2.05M |
| 3 |
ABB
ABB Ltd.
ABB
|
$1.86M |
| 4 |
Rayonier
RYN
|
$1.35M |
| 5 |
Healthpeak Properties
DOC
|
$1.02M |
Sector Composition
| 1 | Healthcare | 25.17% |
| 2 | Consumer Staples | 12.87% |
| 3 | Industrials | 12.22% |
| 4 | Technology | 9.03% |
| 5 | Communication Services | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42.1B
| $4.86M | 7.22% |
52,980
+21,060
| +66% | +$1.93M |
|
|
2
iShares Short Treasury Bond ETF
SHV
$20.8B
| $2.66M | 3.95% |
23,940
+8,310
| +53% | +$923K |
|
3
Novo Nordisk
NVO
$251B
| $2.58M | 3.84% |
42,920
+15
| +0% | +$903 |
|
4
Costco
COST
$418B
| $2.51M | 3.73% |
8,803
-63
| -0.7% | -$18K |
|
5
Kroger
KR
$44.9B
| $2.44M | 3.62% |
80,885
-2,590
| -3% | -$78K |
|
6
Cencora
COR
$56.5B
| $1.91M | 2.84% |
21,563
-800
| -4% | -$70.8K |
|
|
CERN
7
DELISTED
Cerner Corp
CERN
| $1.82M | 2.7% |
28,850
-345
| -1% | -$21.7K |
|
8
Intel
INTC
$107B
| $1.79M | 2.66% |
33,029
-843
| -2% | -$45.6K |
|
9
PACCAR
PCAR
$52.5B
| $1.72M | 2.56% |
28,150
+655
| +2% | +$40K |
|
10
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.67M | 2.48% |
1,433
+22
| +2% | +$25.6K |
|
11
US Bancorp
USB
$76B
| $1.65M | 2.45% |
47,900
-4,900
| -9% | -$169K |
|
12
PetMed Express
PETS
$63.4M
| $1.62M | 2.4% |
56,115
-2,400
| -4% | -$69.1K |
|
|
13
3M
MMM
$82.8B
| $1.51M | 2.25% |
11,080
+8,260
| +293% | +$1.13M |
|
14
Merck
MRK
$210B
| $1.44M | 2.14% |
18,709
-9,810
| -34% | -$755K |
|
15
F5
FFIV
$18B
| $1.41M | 2.1% |
13,260
+505
| +4% | +$53.9K |
|
|
16
Gilead Sciences
GILD
$140B
| $1.41M | 2.1% |
18,907
+10,415
| +123% | +$778K |
|
17
Eli Lilly
LLY
$657B
| $1.4M | 2.08% |
10,066
-45
| -0.4% | -$6.24K |
|
18
Verizon
VZ
$186B
| $1.34M | 1.99% |
24,935
-5,600
| -18% | -$301K |
|
19
Omnicom Group
OMC
$15.2B
| $1.32M | 1.96% |
24,023
+240
| +1% | +$13.2K |
|
20
Goldman Sachs
GS
$226B
| $1.31M | 1.95% |
8,465
+110
| +1% | +$17K |
|
21
Cognizant
CTSH
$35.3B
| $1.26M | 1.88% |
27,140
+985
| +4% | +$45.8K |
|
22
Coca-Cola
KO
$297B
| $1.26M | 1.87% |
28,395
-1,250
| -4% | -$55.3K |
|
23
Acuity Brands
AYI
$10B
| $1.21M | 1.8% |
14,101
+330
| +2% | +$28.2K |
|
24
Edwards Lifesciences
EW
$47.8B
| $1.19M | 1.77% |
6,300
| – | – |
|
25
Chevron
CVX
$324B
| $1.13M | 1.68% |
15,620
-986
| -6% | -$71.5K |
|